pathology
study of disease
aetiology
causation
pathogenesis
progression of disease leading to effects on cells, tissues, and organs
potential causes of disease
molecular manifestations of disease
changes in protein
- expression
- structure
- function
cellular manifestations of disease
changes in cell
- number
- morphology
tissue/organ manifestations of disease
gross changes in
- structure
- function
BCR-ABL kinase
novel protein
- promotes cell proliferation
- impairs DNA repair
- induces genomic instability
causes >90% of chronic myeloid leukaemia cases but found in other cancers too
aetiology of BCR-ABL kinase expression
chromosomal translocation between chromosomes 9 and 22 forming BCR-ABL fusion gene
pathogenesis of BCR-ABL kinase
diagnostic techniques investigate
potential changes associated with
- aetiology
- pathogenesis
what is something that halts pcr extension
extension cannot continue through a primer
DNA polymerase PCR cofactor
magnesium chloride
BCR-ABL treatment
targeted drug therapy
BCR-ABL test
BCR pcr - control for primers
BCR-ABL pcr - test for fusion gene
what is the importance of controls
to ensure all protocols are functioning appropriately to give an accurate result
importance of non-template control
to gauge whether contamination has taken place
benefits of PCR multiplex to test for BCR-ABL
the BCR PCR can be used as a negative control
what would a negative BCR-ABL test mean for a leukaemia patient
the BCR-ABL gene is not responsible for their leukaemia
why are enzymes used for diagnostic IHC
they often don’t have the required microscope for fluorescent tag visualisation
benefits of fluorescent tags for IHC
can put lots of tags on
key stages of IHC
purpose of IHC
identify the expression of specific proteins in a tissue sample
what principle does IHC rely on
all proteins are potential antigens detectable to the immune system so it is possible to generate an antibody that will bind to specific proteins.